INTERNATIONAL PATENT: GENECENTRIC THERAPEUTICS, INC. FILES APPLICATION FOR "METHOD FOR USING CIRCULATING TUMOR DNA FOR CANCER SUBTYPING"

GENEVA, July 10 -- GENECENTRIC THERAPEUTICS, INC. (100 Capitola Dr., Suite 275Durham, North Carolina 27713) filed a patent application (PCT/US2024/060700) for "METHOD FOR USING CIRCULATING TUMOR DNA FOR CANCER SUBTYPING" on Dec 18, 2024. With publication no. WO/2025/144650, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUO, Yuelong (c/o GeneCentric Therapeutics, Inc.100 Capitola Dr., Suite 275Durham, North Carolina 27713), SHIBATA, Yoichiro (c/o GeneCentric Therapeutics, Inc.100 Capitola Dr., Suite 275Durham, North Caro...